Europe PMC in 2023.

Europe PMC (https://europepmc.org/) is an open access database of life science journal articles and preprints, which contains over 42 million abstracts and over 9 million full text articles accessible via the website, APIs and bulk download. This publication outlines new developments to the Europe PMC platform since the last database update in 2020 (1) and focuses on five main areas. (i) Improving discoverability, reproducibility and trust in preprints by indexing new preprint content, enriching preprint metadata and identifying withdrawn and removed preprints. (ii) Enhancing support for text and data mining by expanding the types of annotations provided and developing the Europe PMC Annotations Corpus, which can be used to train machine learning models to increase their accuracy and precision. (iii) Developing the Article Status Monitor tool and email alerts, to notify users about new articles and updates to existing records. (iv) Positioning Europe PMC as an open scholarly infrastructure through increasing the portion of open source core software, improving sustainability and accessibility of the service.

The next-generation Open Targets Platform: reimagined, redesigned, rebuilt.

The Open Targets Platform (https://platform.opentargets.org/) is an open source resource to systematically assist drug target identification and prioritisation using publicly available data. Since our last update, we have reimagined, redesigned, and rebuilt the Platform in order to streamline data integration and harmonisation, expand the ways in which users can explore the data, and improve the user experience. The gene-disease causal evidence has been enhanced and expanded to better capture disease causality across rare, common, and somatic diseases. For target and drug annotations, we have incorporated new features that help assess target safety and tractability, including genetic constraint, PROTACtability assessments, and AlphaFold structure predictions. We have also introduced new machine learning applications for knowledge extraction from the published literature, clinical trial information, and drug labels. The new technologies and frameworks introduced since the last update will ease the introduction of new features and the creation of separate instances of the Platform adapted to user requirements. Our new Community forum, expanded training materials, and outreach programme support our users in a range of use cases.

Europe PMC in 2020.

Europe PMC (https://europepmc.org) is a database of research articles, including peer reviewed full text articles and abstracts, and preprints - all freely available for use via website, APIs and bulk download. This article outlines new developments since 2017 where work has focussed on three key areas: (i) Europe PMC has added to its core content to include life science preprint abstracts and a special collection of full text of COVID-19-related preprints. Europe PMC is unique as an aggregator of biomedical preprints alongside peer-reviewed articles, with over 180 000 preprints available to search. (ii) Europe PMC has significantly expanded its links to content related to the publications, such as links to Unpaywall, providing wider access to full text, preprint peer-review platforms, all major curated data resources in the life sciences, and experimental protocols. The redesigned Europe PMC website features the PubMed abstract and corresponding PMC full text merged into one article page; there is more evident and user-friendly navigation within articles and to related content, plus a figure browse feature. (iii) The expanded annotations platform offers ∼1.3 billion text mined biological terms and concepts sourced from 10 providers and over 40 global data resources.

Probabilistic broken-stick model: A regression algorithm for irregularly sampled data with application to eGFR.

In order for clinicians to manage disease progression and make effective decisions about drug dosage, treatment regimens or scheduling follow up appointments, it is necessary to be able to identify both short and long-term trends in repeated biomedical measurements. However, this is complicated by the fact that these measurements are irregularly sampled and influenced by both genuine physiological changes and external factors. In their current forms, existing regression algorithms often do not fulfil all of a clinician's requirements for identifying short-term (acute) events while still being able to identify long-term, chronic, trends in disease progression. Therefore, in order to balance both short term interpretability and long term flexibility, an extension to broken-stick regression models is proposed in order to make them more suitable for modelling clinical time series. The proposed probabilistic broken-stick model can robustly estimate both short-term and long-term trends simultaneously, while also accommodating the unequal length and irregularly sampled nature of clinical time series. Moreover, since the model is parametric and completely generative, its first derivative provides a long-term non-linear estimate of the annual rate of change in the measurements more reliably than linear regression. The benefits of the proposed model are illustrated using estimated glomerular filtration rate as a case study used to manage patients with chronic kidney disease.

Pediatrics in Artificial Intelligence Era: A Systematic Review on Challenges, Opportunities, and Explainability.

BACKGROUND: The emergence of artificial intelligence (AI) tools such as ChatGPT and Bard is disrupting a broad swathe of fields, including medicine. In pediatric medicine, AI is also increasingly being used across multiple subspecialties. However, the practical application of AI still faces a number of key challenges. Consequently, there is a requirement for a concise overview of the roles of AI across the multiple domains of pediatric medicine, which the current study seeks to address. AIM: To systematically assess the challenges, opportunities, and explainability of AI in pediatric medicine. METHODOLOGY: A systematic search was carried out on peer-reviewed databases, PubMed Central, Europe PubMed Central, and grey literature using search terms related to machine learning (ML) and AI for the years 2016 to 2022 in the English language. A total of 210 articles were retrieved that were screened with PRISMA for abstract, year, language, context, and proximal relevance to research aims. A thematic analysis was carried out to extract findings from the included studies. RESULTS: Twenty articles were selected for data abstraction and analysis, with three consistent themes emerging from these articles. In particular, eleven articles address the current state-of-the-art application of AI in diagnosing and predicting health conditions such as behavioral and mental health, cancer, syndromic and metabolic diseases. Five articles highlight the specific challenges of AI deployment in pediatric medicines: data security, handling, authentication, and validation. Four articles set out future opportunities for AI to be adapted: the incorporation of Big Data, cloud computing, precision medicine, and clinical decision support systems. These studies collectively critically evaluate the potential of AI in overcoming current barriers to adoption. CONCLUSION: AI is proving disruptive within pediatric medicine and is presently associated with challenges, opportunities, and the need for explainability. AI should be viewed as a tool to enhance and support clinical decision-making rather than a substitute for human judgement and expertise. Future research should consequently focus on obtaining comprehensive data to ensure the generalizability of research findings.

Machine Learning in Pediatrics: Evaluating Challenges, Opportunities, and Explainability.

BACKGROUND: The emergence of Artificial Intelligence (AI) tools such as ChatGPT and Bard is disrupting a broad swathe of fields, including medicine. In pediatric medicine, AI is also increasingly being used across multiple subspecialties. However, the practical application of AI still faces a number of key challenges. Consequently, there is a requirement for a concise overview of the roles of AI across the multiple domains of pediatric medicine that the current study seeks to address. AIM: To systematically assess the challenges, opportunities, and explainability of AI in pediatric medicine. METHODOLOGY: A systematic search was carried out on peer-reviewed databases, PubMed Central, Europe PubMed Central, and grey literature using search terms related to machine learning (ML) and AI for the years 2016 to 2022 in the English language. A total of 210 articles were retrieved that were screened with PRISMA for abstract, year, language, context, and proximal relevance to research aims. A thematic analysis was carried out to extract findings from the included studies. RESULTS: Twenty articles were selected for data abstraction and analysis, with three consistent themes emerging from these articles. In particular, eleven articles address the current state-of-the-art application of AI in diagnosing and predicting health conditions such as behavioral and mental health, cancer, syndromic and metabolic diseases. Five articles highlight the specific challenges of AI deployment in pediatric medicines: data security, handling, authentication, and validation. Four articles set out future opportunities for AI to be adapted: the incorporation of Big Data, cloud computing, precision medicine, and clinical decision support systems. These studies collectively critically evaluate the potential of AI in overcoming current barriers to adoption. CONCLUSION: AI is proving disruptive within pediatric medicine and is presently associated with challenges, opportunities, and the need for explainability. AI should be viewed as a tool to enhance and support clinical decision-making rather than a substitute for human judgement and expertise. Future research should consequently focus on obtaining comprehensive data to ensure the generalizability of research findings.

Visual attribution using Adversarial Latent Transformations.

The ability to accurately locate all indicators of disease within medical images is vital for comprehending the effects of the disease, as well as for weakly-supervised segmentation and localization of the diagnostic correlators of disease. Existing methods either use classifiers to make predictions based on class-salient regions or else use adversarial learning based image-to-image translation to capture such disease effects. However, the former does not capture all relevant features for visual attribution (VA) and are prone to data biases; the latter can generate adversarial (misleading) and inefficient solutions when dealing in pixel values. To address this issue, we propose a novel approach Visual Attribution using Adversarial Latent Transformations (VA2LT). Our method uses adversarial learning to generate counterfactual (CF) normal images from abnormal images by finding and modifying discrepancies in the latent space. We use cycle consistency between the query and CF latent representations to guide our training. We evaluate our method on three datasets including a synthetic dataset, the Alzheimer's Disease Neuroimaging Initiative dataset, and the BraTS dataset. Our method outperforms baseline and related methods on all datasets.

Europe PMC annotated full-text corpus for gene/proteins, diseases and organisms.

Named entity recognition (NER) is a widely used text-mining and natural language processing (NLP) subtask. In recent years, deep learning methods have superseded traditional dictionary- and rule-based NER approaches. A high-quality dataset is essential to fully leverage recent deep learning advancements. While several gold-standard corpora for biomedical entities in abstracts exist, only a few are based on full-text research articles. The Europe PMC literature database routinely annotates Gene/Proteins, Diseases, and Organisms entities. To transition this pipeline from a dictionary-based to a machine learning-based approach, we have developed a human-annotated full-text corpus for these entities, comprising 300 full-text open-access research articles. Over 72,000 mentions of biomedical concepts have been identified within approximately 114,000 sentences. This article describes the corpus and details how to access and reuse this open community resource.

A novel kernel based approach to arbitrary length symbolic data with application to type 2 diabetes risk.

Predictive modeling of clinical data is fraught with challenges arising from the manner in which events are recorded. Patients typically fall ill at irregular intervals and experience dissimilar intervention trajectories. This results in irregularly sampled and uneven length data which poses a problem for standard multivariate tools. The alternative of feature extraction into equal-length vectors via methods like Bag-of-Words (BoW) potentially discards useful information. We propose an approach based on a kernel framework in which data is maintained in its native form: discrete sequences of symbols. Kernel functions derived from the edit distance between pairs of sequences may then be utilized in conjunction with support vector machines to classify the data. Our method is evaluated in the context of the prediction task of determining patients likely to develop type 2 diabetes following an earlier episode of elevated blood pressure of 130/80 mmHg. Kernels combined via multi kernel learning achieved an F1-score of 0.96, outperforming classification with SVM 0.63, logistic regression 0.63, Long Short Term Memory 0.61 and Multi-Layer Perceptron 0.54 applied to a BoW representation of the data. We achieved an F1-score of 0.97 on MKL on external dataset. The proposed approach is consequently able to overcome limitations associated with feature-based classification in the context of clinical data.

Movement correction in DCE-MRI through windowed and reconstruction dynamic mode decomposition.

Images of the kidneys using dynamic contrast-enhanced magnetic resonance renography (DCE-MRR) contains unwanted complex organ motion due to respiration. This gives rise to motion artefacts that hinder the clinical assessment of kidney function. However, due to the rapid change in contrast agent within the DCE-MR image sequence, commonly used intensity-based image registration techniques are likely to fail. While semi-automated approaches involving human experts are a possible alternative, they pose significant drawbacks including inter-observer variability, and the bottleneck introduced through manual inspection of the multiplicity of images produced during a DCE-MRR study. To address this issue, we present a novel automated, registration-free movement correction approach based on windowed and reconstruction variants of dynamic mode decomposition (WR-DMD). Our proposed method is validated on ten different healthy volunteers' kidney DCE-MRI data sets. The results, using block-matching-block evaluation on the image sequence produced by WR-DMD, show the elimination of 99 % of mean motion magnitude when compared to the original data sets, thereby demonstrating the viability of automatic movement correction using WR-DMD.